We had sufficient statistical power to observe a moderate effect size (difference of 2.35 on the PIPP score) between the treatment groups.
We observed a moderate enhancer effect on the PADI2 gene and the SV40 virus promoter regions in the presence of 1.5 mM calcium.
Although we could not distinguish appropriate respiratory protection from inappropriate, we observed a moderate protective effect of mask or respirator use.
We observed a moderate alleviation of the antagonistic effect of ATR on GH protein levels.
For H292, concentrations around IC20 were required (DEF = 1.36) to observe a moderate synergistic effect, and for CAL-27 cells, concentrations around IC45 (DEF = 1.92) resulted in clear synergism.
However, in the case of red QDs treatment, a high modulation in genes related to transport (almost 4-fold higher than that observed with green QDs) and a moderate effect on genes involved in glycolysis and tricarboxylic acid cycle were observed.
With respect to the effect of indomethacin after 2 h, a similar tendency were observed for compounds 8 and 15; 1, 5 8, 11, 13, 16, 17 and 20 showed a comparable good activity; a moderate effect was observed by 2 4, 10, 14 and 19, however, compound 9 showed a stronger effect (72.72%) than indomethacin (61.22%).
4 h after drug administration, compounds 1, 6, 8, 9, and 13 18 exhibited remarkable and significant activity (51.67 67.20%) compared to indomethacin (85.70%); a moderate effect was observed for compounds 3 5, 7 and 11 (32.81–46.66%), and compounds 2, 10, 12 and 19 showed the lowest potency (Fig. 1).
Incubation with low concentrations of the extract (1 μg/mL) did not significantly affect kinetic parameters of the aggregation process, and a moderate effect was observed for platelet-rich plasma incubated with 10 μg/mL of chokeberry.
Only in adolescents did we observe a significant gender difference with a moderate effect size.
